Global Hepatitis Drugs Market to grow at a CAGR of 17.1% over the period 2014 - 2019, Finds New Report

Report forecast the global hepatitis drugs market to grow at a CAGR of 17.1% over the period 2014-2019.

Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either acute or chronic infections.

The report includes the present scenario and the growth prospects of the global hepatitis drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of hepatitis.

Global Hepatitis Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as the segmentation. The report includes a discussion of the key vendors operating in this market.

According to the report, early detection of hepatitis is important in reducing the chances of developing liver infections, which can prevent extensive liver damage. Various government and non-government organizations organize awareness campaigns and other programs to educate people about the disease and therapeutic measures available.

Key regions

• Americas
• APAC
• EMEA

Key players in the Global Hepatitis Drugs Market:  F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis and Vertex Pharmaceuticals

Other Prominent Vendors in the market are: Abbvie, Achillion Pharmaceuticals, Bristol-Myers Squibb,  Dynavax Technologies and Mitsubishi Tanabe Pharma

Key market driver

• Emergence of IFN-free therapies
• For a full, detailed list, view our report

Key market challenge

• Side-effects of current therapy
• For a full, detailed list, view our report

Key market trend

• Collaborations and M&A
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 118 pages, “Global Hepatitis Drugs Market 2015 - 2019” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Disease overview, Key marketed drugs, Market landscape, Market segmentation by type, Market segmentation by MOA, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Find more information Visit at: http://mrr.cm/oLC

Related Report:

Global Left Atrial Appendage (LAA) Closure Market 2016-2020 - visit at: http://mrr.cm/oLy